← FDA DRUG APPROVALS

FDA ANDA · ANDA087731

UROVIST CYSTO PEDIATRIC

Sponsor: BAYER HLTHCARE

APPLICATION
ANDA087731
TYPE
ANDA
ORIGINAL APPROVAL
1982-09-23
LATEST ACTION
1991-07-09
ROUTE
URETERAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

UROVIST CYSTO PEDIATRICDiscontinued
DIATRIZOATE MEGLUMINE 30% · SOLUTION · URETERAL

Approval history

1991-07-09Labeling · Supplement 5AP
1982-09-23OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →